Team:Goettingen/Human Practice/Panel Discussion

From 2012.igem.org

(Difference between revisions)
Line 592: Line 592:
<br>
<br>
<br>
<br>
-
In addition, we are very pleased with the announcement of <b>Dr. Günter Strittmatter</b> to participate in our discussion. Dr. Strittmatter absolved his studies in biology at the University of Freiburg, where he also received his PhD. Subsequently he worked several years as a postdoc at the Rockefeller University of New York, USA. After his stay abroad he took a position as project manager at the Max Planck institute for breeding research in Köln. Here, he mainly worked on the genetic generation of fungal resistance in plants.
+
<img width="170" src="https://static.igem.org/mediawiki/2012/9/91/Goett_strittmatter.png"></td><td>In addition, we are very pleased with the announcement of <b>Dr. Günter Strittmatter</b> to participate in our discussion. Dr. Strittmatter absolved his studies in biology at the University of Freiburg, where he also received his PhD. Subsequently he worked several years as a postdoc at the Rockefeller University of New York, USA. After his stay abroad he took a position as project manager at the Max Planck institute for breeding research in Köln. Here, he mainly worked on the genetic generation of fungal resistance in plants.
<br>  
<br>  
Afterwards, Dr. Strittmatter was employed as project manager for the company Planta Genetic Systems in Gent (PGS), Belgium for a year.  
Afterwards, Dr. Strittmatter was employed as project manager for the company Planta Genetic Systems in Gent (PGS), Belgium for a year.  
<br>
<br>
-
Since 1998 Dr. Strittmatter acts on behalf of KWS, our head sponsor, where he leads the institute for plant breeding. Hence we extend a warm welcome to him and are very excited to hear about the topic of Synthetic Biology from an enterpriser’s point of view.  
+
Since 1998 Dr. Strittmatter acts on behalf of KWS, our head sponsor, where he leads the institute for plant breeding. Hence we extend a warm welcome to him and are very excited to hear about the topic of Synthetic Biology from an enterpriser’s point of view. </td></tr></table>
<br>
<br>
<br>
<br>

Revision as of 21:02, 11 September 2012